AKRX News 34.00 08/04/2014 04:30:19 Akorn Inc (AKRX)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Akorn Inc (AKRX) 34.00 $AKRX

Salix, Actavis Lead IBD 50 Drug Earnings This Week
at Investor's Business Daily - Sat Aug 02, 7:02AM CDT
Salix Pharmaceuticals (SLXP), which announced its tax inversion merger last month, will be among several IBD 50 drug stocks to report earnings this week. In July, Salix announced plans to merge with Italy's Cosmo Pharmaceuticals' Irish subsidiary,...

Akorn Shares Up 38.2% Since SmarTrend's Buy Recommendation (AKRX)
Comtex SmarTrend(R) - Thu Jul 31, 5:16PM CDT
SmarTrend identified an Uptrend for Akorn (NASDAQ:AKRX) on April 22nd, 2014 at $24.55. In approximately 3 months, Akorn has returned 38.21% as of today's recent price of $33.93.

Global Parkinson's Disease Market 2014-2018: Key Vendors are Boehringer Ingelheim, GlaxoSmithKline, Novartis and Teva
M2 - Thu Jul 31, 5:48AM CDT
Research and Markets (http://www.researchandmarkets.com/research/l95k93/global) has announced the addition of the "Global Parkinson's Disease Market 2014-2018" report to their offering. Parkinson's disease is a progressive neurodegenerative disorder characterized by damage of dopaminergic neurons located in various parts of brain including the substantia nigra. This lowers the concentration of dopamine in the striatum. A decrease in dopamine levels by 80 percent leads to the development of symptoms associated with Parkinson's disease such as tremor, bradykinesia, and muscular rigidity. It is usually diagnosed in the population aged 60 and over; however, earlier incidences have been reported. Based on the severity, it can be categorized into early stage, mid stage and late (or advanced) stage. Currently, the approved therapies provide only symptomatic relief. Levodopa is the standard drug for the treatment of Parkinson's disease; however, it is associated with the incidence of dyskinesias. Alternative surgical procedures such as bilateral globus pallidus interna stimulation and bilateral subthalamic nucleus stimulation can be used in Parkinson's disease patients under certain circumstances. Key Topics Covered: 01. Executive Summary 02. List of Abbreviations 03. Scope of the Report 04. Market Research Methodology 05. Introduction 06. Market Landscape 07. Market Segmentation by MOA 08. Geographical Segmentation 09. Buying Criteria 10. Market Growth Drivers 11. Drivers and their Impact 12. Market Challenges 13. Impact of Drivers and Challenges 14. Market Trends 15. Trends and their Impact 16. Vendor Landscape 17. Key Late-Stage Pipeline Candidates 18. Other Prominent Vendors 19. Key Vendor Analysis 20. Other Reports in this Series Companies Mentioned: - Boehringer Ingelheim GmbH - GlaxoSmithKline plc - Novartis AG - Teva Pharmaceutical Industries Ltd. - Abbvie Inc. - Akorn Inc. - Astellas Pharma Inc. - Desitin Arzneimittel GmbH - Endo International plc - F. Hoffmann-La Roche Ltd. - H. Lundbeck A/S - Kyowa Hakko Kirin - Merck & Co. Inc. - Orion Corp. - STADA Arzneimittel AG - UCB Inc. - US WorldMeds LLC - Valeant Pharmaceuticals International Inc. For more information visit http://www.researchandmarkets.com/research/l95k93/global

Uptrend Call Working As Akorn Stock Rises 41.5% (AKRX)
Comtex SmarTrend(R) - Thu Jul 24, 4:41PM CDT
SmarTrend identified an Uptrend for Akorn (NASDAQ:AKRX) on April 22nd, 2014 at $24.55. In approximately 3 months, Akorn has returned 41.47% as of today's recent price of $34.73.

Acasti Pharma (ACST) Jumps: Stock Moves 7.3% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Jul 24, 8:46AM CDT
Acasti Pharma (ACST) was a big mover last session, with shares rising over 7% on the day.

Uptrend Call Working As Akorn Stock Rises 35.7% (AKRX)
Comtex SmarTrend(R) - Thu Jul 17, 11:02AM CDT
SmarTrend identified an Uptrend for Akorn (NASDAQ:AKRX) on April 22nd, 2014 at $24.55. In approximately 3 months, Akorn has returned 35.72% as of today's recent price of $33.32.

Market Losses Its Swagger In Afternoon Trade
at Investor's Business Daily - Wed Jul 16, 3:26PM CDT
Wednesday's stock market opened with a swagger, but closed with a stagger as it gave up a good chunk of a morning bounce. The Nasdaq rose 0.2%; the S&P 500 and the Dow Jones industrial average gained 0.4%. Volume was higher on the Nasdaq and lower on...

Stocks Recover From Early Fade; Whiting Hits New High
at Investor's Business Daily - Wed Jul 16, 12:35PM CDT
Stocks were again off their session highs but have regained some momentum. The Nasdaq, S&P 500 and Dow Jones industrial average were each up 0.4%. Earlier, the Nasdaq and S&P 500 retraced most of their morning gains. Turnover was again tracking mixed...

Adamas Pharmaceuticals, Inc. (ADMS) in Focus: Stock Rises 7.04% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Jul 16, 7:44AM CDT
Adamas Pharmaceuticals, Inc. (ADMS) was a big mover last session, as the company saw its shares rise 7% on the day.

Akorn, Inc. Announces Second Quarter 2014 Earnings Release and Conference Call Information
GlobeNewswire - Wed Jul 16, 3:52AM CDT
Akorn, Inc. (Nasdaq:AKRX) will host a conference call on Tuesday, August 5, 2014, to discuss second quarter 2014 results followed by a Q&A session. The company will release earnings the same day before the market opens.

Progenics Pharmaceuticals, Inc. (PGNX) in Focus: Stock Rises 8.5% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Jul 15, 7:44AM CDT
Progenics Pharmaceuticals, Inc. (PGNX) was a big mover last session, as the company saw its shares rise over 8% on the day.

Stocks Recover Impressively; Gap Slumps In After Hours
at Investor's Business Daily - Thu Jul 10, 4:22PM CDT
Major averages ended with modest losses Thursday, recovering impressively after an early sell-off. Wall Street was rattled early over newfound concerns about the health of European banks after Espirito Santo International, the parent company of...

Supernus Up on Non-Dilutive Royalty Deal - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jul 10, 3:43PM CDT
Supernus Pharmaceuticals, Inc.'s (SUPN) inked a non-dilutive royalty deal worth $30 million with HealthCare Royalty Partners.

Stocks Claw Way Back After Morning Sell-Off
at Investor's Business Daily - Thu Jul 10, 12:42PM CDT
Stocks continued to claw their way back from opening losses Thursday, with the indexes coming more than halfway back in early-afternoon trading. The Nasdaq and S&P 500 fell less than 0.4% and the Dow Jones industrial average was off 0.5%. Volume was...

Shares of AKRX Up 32.6% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Thu Jul 10, 9:41AM CDT
SmarTrend identified an Uptrend for Akorn (NASDAQ:AKRX) on April 22nd, 2014 at $24.55. In approximately 3 months, Akorn has returned 32.59% as of today's recent price of $32.55.

Acasti Pharma Inc. (ACST) Jumps: Stock Rises 7.6% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Jul 10, 8:21AM CDT
Acasti Pharma Inc. (ACST) was a big mover last session, as the company saw its shares rise by roughly 8% on the day.

Walgreens Sees Robust Growth in June Sales - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Jul 08, 5:20PM CDT
Walgreens (WAG) opened 39 new drug stores in the third-quarter of fiscal 2014 in an attempt to optimize its store footprint.

Teva's Contraceptive Gets Positive CHMP Opinion - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Jul 07, 5:00PM CDT
Teva Pharmaceutical Industries Ltd.'s (TEVA) extended-regimen oral contraceptive, Seasonique got a positive recommendation from theCommittee for Medicinal Products for Human Use.

Stocks Add To Losses; TAL Education Bucks Weakness
at Investor's Business Daily - Mon Jul 07, 12:41PM CDT
Stocks worsened a little more Monday afternoon, with techs taking the hardest hit. The Nasdaq stretched its loss to 0.7%. Solar, software and biotechs were among the day's worst-performing groups. The S&P 500 and the Dow Jones industrial average lost...
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Mason Adds Nonprofit Expertise to Institutional Bench

Updated Category News Views 110

Endowment committees rarely need more noise; they need somebody who has actually sat through the uncomfortable votes. Mason Investment Advisory Services has hired Rebecca “Becky” Farnsworth, CFA, as a senior investment consultant, and this looks like a practical addition rather than the usual chest-thumping personnel announcement. Her stated focus will be...

Continue Reading
E-Rate Risk and Data Center Rules Demand Attention

Updated Category News Views 71

America’s digital plumbing is getting squeezed at both ends: the public connections nobody notices until they fail, and the industrial-scale computing boom everybody suddenly wants built yesterday. Connected Nation’s two bonus podcast episodes from the Broadband Nation Expo in New Orleans put those pressures side by side, and it is a more useful pairing than it may...

Continue Reading
Delayed Remodels Can Quietly Drain Your Home's Value

Updated Category News Views 51

A pinhole leak has a nasty talent for becoming a demolition budget. That is the plain lesson in Jason Marks' discussion of delayed remodeling for homeowners in Kernersville, North Carolina. People tend to see a worn bathroom, tired kitchen, or drafty window and think, “Not pretty, but it can wait.” Sometimes it can. Sometimes that little delay lets water, rot,...

Continue Reading
Travel Disruptions Reveal the Value of Human Support

Updated Category News Views 95

Air travel’s ugly little secret surfaced again during the recent ground stop: a reservation is easy, but rescuing a trip is labor-intensive, fast-moving work. Internova Travel Group says its people across Travel Leaders Network, Global Travel Collection and ALTOUR moved quickly as cancellations piled up and travelers were left staring at busted itineraries. That is not...

Continue Reading
ADFW 2026 Builds a Bigger Stage for Global Capital

Updated Category News Views 46

Abu Dhabi is not merely booking conference rooms this December; it is assembling a very deliberate display of financial muscle. Abu Dhabi Finance Week runs from 7 to 10 December 2026, and ADGM says its fifth edition will carry its largest-ever programme of partner-led activity. That is a promotional claim, sure, but the partner list is substantial enough that investors...

Continue Reading
Allooloo's 100M Calls Test Capital Markets AI Data

Updated Category News Views 97

Forty-one point nine thousand issuers is a lot of financial clutter to keep straight, and Allooloo says its machines are getting called on to do precisely that at industrial scale. The Vancouver-based company reported on November 20 that its capital-markets data products now receive 100 million AI-agent calls a month—roughly 3.4 million daily, or 39 per second. That is...

Continue Reading
PCS Rental Prep Is About Control Before Distance Hits

Updated Category News Views 99

A vacant house can turn into a long-distance headache with startling speed. For military homeowners preparing for a PCS move, the useful point in Rhonda Leahy's guidance is not glamorous: settle the boring operational stuff before the moving boxes, travel orders, and new-duty-station chaos swallow the calendar. Renting out a former home is not merely collecting enough...

Continue Reading
Cedars-Sinai and nference Build a Living Data Engine

Updated Category News Views 175

Five million patient histories are not a flashy product demo. They are a serious raw-material advantage, provided the data can be protected, organized, and made useful without turning clinical research into a carnival of loose claims. That is the real weight behind nference's long-term collaboration with Cedars-Sinai, announced November 20, 2026. The pair plan to build a...

Continue Reading
Chord's $550 Million Exit Tightens Its Basin Focus

Updated Category News Views 60

One map pin just disappeared from Chord Energy’s corporate wall, and that matters more than the usual deal-closing confetti. Chord has completed the sale of its entire non-operated Marcellus position to POSCO International for $550 million in gross consideration. For shareholders in NASDAQ:CHRD, this is not a flashy new drilling story. It is a cleanup job, and sometimes...

Continue Reading
Classic Chevrolet Gives $1.145M to 13 Local Groups

Updated Category News Views 57

A Thanksgiving Check With Some Real Weight More than a million dollars changing hands before lunch is not the usual holiday fluff, and Classic Chevrolet's planned $1,145,040 donation deserves more than a quick nod. On Tuesday, November 24, at 11 a.m. CST, the Grapevine dealership says it will distribute that sum among 13 nonprofit organizations and charitable programs...

Continue Reading

Top 5 Most Recently Viewed Articles

Natural Food Color Industry Expected to Thrive by 2035

Updated Category News Views 167

Revitalizing the Natural Food Colors Market The natural food colors market is poised for remarkable growth, projected to expand from USD 2.01 billion to USD 4.03 billion by 2035. Market analysts suggest this surge will take place at a Compound Annual Growth Rate (CAGR) of 7.8%. This transformation is largely attributed to a shift in consumer preferences, regulatory...

Continue Reading
Fang Holdings Strengthens Leadership with Board Changes

Updated Category News Views 98

Fang Holdings Limited Announces Leadership Changes Fang Holdings Limited (OTC: SFUNY) has officially confirmed changes within its board of directors, marking an important phase for the company. As a prominent real estate Internet portal, Fang is committed to providing exceptional services to its users, and these changes in leadership are expected to support its strategic...

Continue Reading
NovaBridge's Visara Appoints Leaders to Propel Eye Treatment

Updated Category News Views 235

NovaBridge's Strategic Moves in Ophthalmology In a significant step forward for innovative treatment in ophthalmology, NovaBridge Biosciences (NASDAQ: NBP) has announced new appointments at its subsidiary, Visara, Inc. Cadmus C. Rich, MD, MBA, has been named Chief Medical Officer, while Carlos Quezada-Ruiz, MD, FASRS, takes the role of Chair of the Scientific Advisory...

Continue Reading
Celebrating Excellence: The Grossman Group's 25-Year Journey

Updated Category News Views 274

The Grossman Group Celebrates 25 Years of Communication Excellence In a prestigious recognition, The Grossman Group has earned the title of Best Small Agency at the Public Relations Society of America's 2025 Silver Anvil Awards. This honor comes during a significant milestone—the company's 25th anniversary—marked by years of dedication to enhancing internal...

Continue Reading
GiGi's Playhouse Celebrates the Opening of Its 61st Center in the Northwest

Updated Category News Views 360

GiGi's Playhouse unveiled its 61st Achievement Center back in the fall of a recent year, pushing forward its mission to uplift individuals impacted by Down syndrome. The grand opening of this center wasn’t just another launch—it was a culmination of seven years filled with passion, community spirit, and unwavering dedication from parents who aimed to create a haven...

Continue Reading